American Shared Hospital Services  

(Public, NYSEMKT:AMS)   Watch this stock  
Find more results for NYSEAMEX:AMS
0.00 (0.00%)
Feb 11 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.50 - 2.86
Open     -
Vol / Avg. 0.00/3,197.00
Mkt cap 9.79M
P/E     -
Div/yield     -
EPS -0.32
Shares 5.36M
Beta 0.47
Inst. own 9%
Mar 28, 2016
Q4 2015 American Shared Hospital Services Earnings Release (Estimated) Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 5.83% -3.65%
Operating margin 8.13% -4.03%
EBITD margin - 52.10%
Return on average assets 1.61% -0.81%
Return on average equity 0.87% -4.64%
Employees 9 -
CDP Score - -


4 Embarcadero Ctr Ste 3700
SAN FRANCISCO, CA 94111-4107
United States - Map
+1-415-7885300 (Phone)
+1-415-7885660 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


American Shared Hospital Services provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to over 18 medical centers in approximately 17 states in the United States. The Company provides Gamma Knife services through its 81% indirect interest in GK Financing, LLC. The Company provides the equipment, as well as planning, installation, reimbursement and marketing support services. Gamma Knife stereotactic radiosurgery is a non-invasive procedure, which is an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Its radiation therapy business consists of one Image Guided Radiation Therapy Operations (IGRT) system. IGRT technology integrates imaging and detection components into a linear accelerator, allowing clinicians to plan treatment, verify positioning and deliver treatment with a single device, providing radiation therapy with less damage to healthy tissue.

Officers and directors

Ernest A. Bates M.D. Chairman of the Board, Chief Executive Officer
Age: 78
Bio & Compensation  - Reuters
Craig Kenji Tagawa Senior Vice President, Chief Operating Officer, Chief Financial Officer
Age: 61
Bio & Compensation  - Reuters
Ernest R. Bates Vice President - Sales and Business Development
Age: 48
Bio & Compensation  - Reuters
John F. Ruffle Lead Independent Director
Age: 78
Bio & Compensation  - Reuters
S. Mert Ozyurek Director
Age: 40
Bio & Compensation  - Reuters
David A. Larson M.D., Ph.D. Independent Director
Age: 74
Bio & Compensation  - Reuters
Raymond C. Stachowiak Independent Director
Age: 57
Bio & Compensation  - Reuters
Stanley S. Trotman Jr. Independent Director
Age: 71
Bio & Compensation  - Reuters